PROMACTA

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0078-0697
  • Package NDC 0078-0697-61
  • Application number NDA207027
  • SPL ID b8a1cc48-9aaf-486a-9305-090acccb5c02
  • SPL set ID 7714a0ed-34bb-46e6-a0a5-b363908b22c2
  • UNII 4U07F515LG
  • RxCUI 825421
  • RxCUI 825425
  • RxCUI 825427
  • RxCUI 825429
  • RxCUI 884617
  • RxCUI 884619
  • RxCUI 1245001
  • RxCUI 1245003
  • RxCUI 1859498
  • RxCUI 1859501
  • RxCUI 2058980
  • RxCUI 2058981

What the source publishes

Labeler
Novartis Pharmaceuticals Corporation
Active ingredients
eltrombopag olamine
Form
POWDER, FOR SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0078-0697_b8a1cc48-9aaf-486a-9305-090acccb5c02
{
  "name": "PROMACTA",
  "splId": "b8a1cc48-9aaf-486a-9305-090acccb5c02",
  "labels": [
    {
      "setId": "7714a0ed-34bb-46e6-a0a5-b363908b22c2",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7714a0ed-34bb-46e6-a0a5-b363908b22c2",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7714a0ed-34bb-46e6-a0a5-b363908b22c2"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Novartis Pharmaceuticals Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 CARTON in 1 KIT (0078-0697-61)  / 30 PACKET in 1 CARTON (0078-0697-23)  / 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0697-19)",
      "package_ndc": "0078-0697-61",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200327"
    }
  ],
  "productId": "0078-0697_b8a1cc48-9aaf-486a-9305-090acccb5c02",
  "useDomain": "unknown",
  "dosageForm": "POWDER, FOR SUSPENSION",
  "productNdc": "0078-0697",
  "deaSchedule": null,
  "genericName": "eltrombopag olamine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ELTROMBOPAG OLAMINE",
      "strength": "25 mg/1"
    }
  ],
  "applicationNumber": "NDA207027",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180927",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "4U07F515LG"
    ],
    "rxcui": [
      "825421",
      "825425",
      "825427",
      "825429",
      "884617",
      "884619",
      "1245001",
      "1245003",
      "1859498",
      "1859501",
      "2058980",
      "2058981"
    ],
    "spl_set_id": [
      "7714a0ed-34bb-46e6-a0a5-b363908b22c2"
    ],
    "manufacturer_name": [
      "Novartis Pharmaceuticals Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0078-0697_b8a1cc48-9aaf-486a-9305-090acccb5c02"